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A B S T R A C T
Technical improvements of imaging devices during the last two dec-
ades have led to the development of so called hybrid imaging modal-
ities, containing at least two different imaging modalities in the same
machine. Hybrid imaging allows the combination of multi-modal im-
ages and the extraction of both complementary and synergistic in-
formation, which is useful for more accurate and reliable diagnosis.
Within this framework there was an increased need for multi-modal
contrast agents. During the last decade development of multi-modal
contrast agents have hence received further attention.
Recent developments of X-ray based imaging techniques now also of-
fers imaging in other regimes, than standard absorption based imag-
ing, e.g. phase contrast imaging, which exploits the refraction and
phase-shift of the incident X-ray beam at tissue-interfaces. It has been
shown that phase contrast imaging is more sensitive than classical
clinical radiography, especially in soft-tissue applications, such as
mammography.
This thesis focuses on evaluating the dual-modal Computed Tomogra-
phy (CT) and Magnetic Resonance Imaging (MRI) capabilities of con-
trast agents. For such purposes a gadolinium based contrast agent
is of high interest, due to its paramagnetic properties, which while
present inside a magnetic field will hence interact with the protons
spins of water (in tissue and fat) and shorten their the T1 relaxation
time, thereby creating a positive image contrast in MRI. Furthermore,
the X-ray Mass Attenuation Coefficient (MAC) of gadolinium is rel-
atively high, thus suggesting its potential use, also as a CT contrast
agent.
Gadolinium nanoparticles can be loaded into cells, such as macro-
phages, which offers the possibility to track cells inside entire organ-
isms. In the first step the uptake of gadolinium nanoparticles inside
cells was investigated, together with a test for toxicity. To show the
potential of using gadolinium nanoparticle loaded macrophages for
functional imaging of inflammation, an acute allergic airway inflam-
mation mouse model (mimicking asthma in humans) was used and
analyzed by in-situ synchrotron phase contrast CT. This animal model
was chosen, since macrophages are one of the main effector cells in
asthma, where especially their ability to migrate is of crucial interest,
which up until now was not possible to study in-situ.
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In the first step this approach was evaluated using macrophages load-
ed with a clinical contrast agent containing barium sulphate, since
this agent is known to provide high contrast in CT. In the ultimate step
a combination of both barium sulphate and gadolinium nanoparticle
loaded macrophages was used in the same mouse model (mimicking
human asthma) and analyzed by dual modal Synchrotron phase con-
trast CT and Micro Magnetic Resonance Imaging (µ-MRI).
Complementary results in terms of the biodistribution of injected
macrophages could only be obtained by the combination of both
synchrotron phase contrast CT and µ-MRI, where the first modality
allows a detailed localization of clustered barium sulphate loaded
macrophages, but fails to detect single macrophages, which could
instead be indirectly observed by µ-MRI as an increase of the T1-
contrast, coming from the soft tissue of mice injected with gadolin-
ium nanoparticle loaded macrophages.
In conclusion, the results obtained on cells loaded with gadolinium
nanoparticles showed that the contrast can not be maximized for both
modalities in parallel, as the MRI-signal decays for higher concentra-
tions of gadolinium. To circumvent this, an alternative pathway could
be to develop a dual-modal contrast agent optimized for MRI in com-
bination with phase contrast CT, instead of absorption based CT.
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P O P U L Ä RV E T E N S K A P L I G S A M M A N FAT T N I N G
Den tekniska förbättringen av bildgivande tekniker under de senaste
två decennierna har lett till utvecklandet av så kallade hybrida bildgi-
vande modaliteter, innehållande minst två stycken olika bildgivande
tekniker i samma system. Hybrid bildgivning möjliggör kombinatio-
nen av multimodala bilder med både komplementär och synergis-
tisk information, vilka kan användas för att ställa en mer noggrann
och tillförlitlig diagnos. Inom detta område ökade därmed behovet av
multimodala kontrastmedel, vilket har varit ett fokus för utveckling
under det senaste decenniet.
Den senaste utvecklingen inom röntgenbaserade bildgivningstekniker
tillåter nu även bildgivning inom fler regimer än vanlig röntgenab-
sorption, t.ex. bildgivning med faskontrast, vilken utnyttjar refraktio-
nen och fasförskjutningen som uppstår när den infallande röntgen-
strålen träffar ytan hos mjukvävnad. Det är bevisat att bildgivning
med faskontrast är mer känslig, än klassisk klinisk radiologi, speciellt
vid undersökning av mjukvävnad, som ex. vid mammografi.
Det här avhandlingsarbetet har syftat till att utvärdera de bimodala
Computed Tomography (CT)- och Magnetic Resonance Imaging (MRI)-
egenskaperna hos kontrastmedel. För sådana ändamål är gadolinium-
baserade kontrastmedel av högt intresse, på grund av dess parmag-
netiska egenskaper, vilka när placerade inuti ett magnetfält kommer
att interagera med protonspinnen hos vatten (i mjukvävnad och fett)
genom att förkorta deras T1-relaxationstid och därmed skapa en posi-
tiv bildkontrast i MRI. Dessutom är massattenueringskoefficienten hos
gadolinium relativt hög, vilket därmed styrker dess potential också
som ett kontrastmedel inom CT.
Gadoliniumnanopartiklar kan tas upp av celler, som ex. makrofager
och man kan därigenom följa cellernas migration inuti en organism.
I ett första steg undersöktes cell-upptaget av gadoliniumnanopartik-
lar, följt av ett toxicitetstest. För att påvisa potentialen av användan-
det av gadoliniumnanopartiklar som ett intracellulärt kontrastmedel
för funktionell bildgivning av inflammation, så analyserades en mus-
modell med akut allergisk luftvägsinflammation (imitation av astma
hos människor) in-situ med synkrotron-faskontrast-CT. Denna djur-
modell valdes ut eftersom makrofager är en av de huvudsakliga effek-
torcellerna vid astma, där deras förmåga att migrera är av avgörande
intresse, vilket var omöjligt att studera in-situ fram till nu.
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Denna metod utvärderades först med makrofager som tagit upp ett
kliniskt kontrastmedel innehållande bariumsulfat, då detta kontrast-
medel påvisats ge god kontrast i CT. I det slutliga steget användes en
kombination av både bariumsulfat och gadoliniumnanopartiklar som
intracellulära kontrastmedel i makrofager i en och samma musmod-
ell (imitation av astma hos människor) och undersöktes med bimodal
synkrotron-faskontrast-CT och µ-MRI.
Komplementära resultat rörande biodistributionen av injicerade makro-
fager kunde endast erhållas tack vare kombinationen av både synkro-
tron-faskontrast-CT och µ-MRI, där den förstnämnda tekniken tillåter
en detaljerad lokalisering av kluster av makrofager med upptaget bar-
iumsulfat, men är otillräcklig för att detektera enskilda makrofager,
vilket å andra sidan indirekt kan observeras i µ-MRI som en ökning av
T1-kontrasten av mjukvävnad i möss injicerade med makrofager som
tagit upp gadoliniumnanopartiklar.
Sammanfattningsvis visade resultaten från cellstudierna att för celler
som tagit upp gadoliniumnanopartiklar kunde kontrasten inte maxi-
meras för båda modaliteterna samtidigt, då Magnetic Resonance (MR)-
signalen förfaller vid en hög koncentration av gadolinium. För att
kringgå detta skulle en alternativ idé vara att utveckla ett bimodalt
kontrastmedel som är optimerat för MRI i kombination med faskontrast-
CT, istället för vanlig röntgenabsorptions-CT
viii
S O M M A R I O
Gli avanzamenti della tecnologia nell’ambito dei dispositivi di imag-
ing avvenuti negli ultimi due decenni hanno portato allo sviluppo
della cosiddetta modalità di imaging ibrido, che prevede l’inserimento
di almeno due diverse modalità di imaging nello stesso macchinario.
L’imaging ibrido consente la combinazione di immagini multimodali
con l’estrazione di informazioni complementari e sinergiche, utili per
una diagnosi più accurata ed affidabile. Di conseguenza, in questo
contesto, è nato e si è andato sviluppando il bisogno di agenti di con-
trasto multimodali che sono stati oggetto, durante l’ultimo decennio,
di una grande attenzione.
Recenti sviluppi delle tecnologie di imaging basate sui raggi X hanno
permesso di ottenere oltre che l’imaging ad assorbimento anche l’imag-
ing a contrasto di fase, che sfrutta la rifrazione e lo sfasamento del fas-
cio incidente di raggi X sulle interfacce dei tessuti. È stato dimostrato
che il contrasto di fase è più sensibile rispetto la classica radiografia
clinica soprattutto nelle applicazioni su tessuti molli, come la mam-
mografia.
La presente tesi si concentra sulla valutazione delle capacità di un
particolare agente di contrasto utilizzabile nel modello ibrido di tomo-
grafia assiale computerizzata (TAC) e di Risonanza Magnetica (RM).
L’agente di contrasto esaminato è a base di gadolinio che presenta
grande interesse a causa delle sue proprietà paramagnetiche. Quando
presenti all’interno di un campo magnetico, tali proprietà consentono
al gadolinio di interagire con gli spin dei protoni delle molecole
d’acqua (presenti nei tessuti e nei grassi), riducendo il tempo di ri-
lassamento T1, migliorando così il contrasto nell’immagine della riso-
nanza magnetica. Inoltre, il coefficiente di attenuazione ai raggi X nel
gadolinio è relativamente alto, suggerendo il suo potenziale uso an-
che come agente di contrasto per la TAC.
D’altra parte alcune tipologie di cellule, come per esempio i macrofagi,
possono essere caricate con nanoparticelle di gadolinio, consentendo
il loro trasporto all’interno degli organismi sino ai punti di interesse
consentendo di realizzare l’imaging funzionale. Durante il dottorato,
in una prima fase oltre allo studio dell’assorbimento di nanoparti-
celle di gadolinio all’interno delle cellule è stato effettuato un test di
tossicità di tali particelle. Per dimostrare le potenzialità dell’utilizzo
delle nanoparticelle di gadolinio, caricate nei macrofagi per l’imaging
funzionale, è stato utilizzato il modello animale (utilizzando i topi)
affetto da una infiammazione allergica acuta (imitando l’asma negli
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esseri umani), analizzando le immagini ottenute mediante contrasto
di fase realizzate col tomografo a luce di sincrotrone. È stato scelto
questo particolare modello animale in quanto i macrofagi attaccano
le cellule presenti nell’asma ed è quindi di particolare interesse studi-
are la loro migrazione, cosa fino ad oggi non possibile da analizzare
in-situ.
Per valutare questo approccio, in una prima fase sono stati utiliz-
zati macrofagi carichi di agenti di contrasto, in particolare contenenti
solfato di bario, noti per garantire un elevato contrasto nelle immag-
ini TAC. In una fase successiva sono state utilizzate le cellule di
macrofagi cariche di nanoparticelle di entrambi gli agenti, solfato di
bario e nanoparticelle di gadolinio, nello stesso modello animale (di
topo, imitando l’asma umana) e sono state analizzate le immagini
acquisite col sistema tomografico bimodale a luce di sincrotrone a
contrasto di fase e µRM.
I risultati in termini di distribuzione dei macrofagi iniettati nei tes-
suti infiammati possono essere ottenuti solo dalla combinazione di
entrambe le modalità di imaging a luce di sincrotrone a contrasto
di fase e di micro risonanza magnetica. La prima modalità consente
una localizzazione dettagliata dell’ammasso dei macrofagi, ma non
rileva il singolo macrofago cariche di solfato di bario, come può in-
vece essere indirettamente osservato dalla µMRI. In questo caso esso
verrebbe rilevato come un aumento del contrasto T1 della risonanza
magnetica, proveniente dai macrofagi caricati con nanoparticelle di
gadolinio e iniettati nel tessuto molle dei topi.
In conclusione, i risultati ottenuti su cellule caricate con nanoparti-
celle al gadolinio mostrarono che il contrasto non può essere mas-
simizzato contemporaneamente per entrambe le metodologie in quan-
to se alte concentrazioni di gadolinio migliorano la qualità di im-
magini tomografiche ad assorbimento, d’altra parte il segnale nella
modalità RM decade per alte concentrazioni di gadolinio. Per super-
are il problema, una strada alternativa potrebbe essere lo sviluppo di
un agente di contrasto bimodale ottimizzato per RM in combinazione
con un sistema tomografico a contrasto di fase, invece dell’utilizzo di
sistemi tomografici ad assorbimento.
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I N T R O D U C T I O N
Many wide spread diseases, such as atherosclerosis, asthma, diabetes
and cancer have inflammation as a common pathway in the disease
progression. Improved possibilities to identify and diagnose sites of
inflammation would therefore be of great interest. As the develop-
ment of hybrid imaging modalities, combining at least two modali-
ties, such as Computed Tomography (CT) and Magnetic Resonance
Imaging (MRI) in one, allowing the extraction of both complementary
and synergistic information, the need for advanced imaging probes
incorporating both CT and MR properties increased. The usage of of
so called multi-modal contrast agents will potentially lead to earlier
and more accurate diagnosis of inflammatory diseases.
1.1 objective
The main objectives of this thesis work were to:
• Distinguish morphological alterations and signs of inflamma-
tion in mouse animal disease models, using a dual-modal CT
and MRI imaging approach.
• evaluate and optimize the efficiency of labeling immune cells
with dual-modal CT-MRI based contrast agents, aiming to track
the homing of these cells to inflammatory sites, using CT and
MRI.
• develop an image processing & analysis scheme, to allow for
quantification of typical morphological hallmarks of lung dis-
eases, in order to characterize the state of the illness, as well
as to monitor treatment response and to allow for a future
combination of therapy and diagnosis (theranostic) approach in
these diseases.
1.2 thesis outline
This thesis is divided into the following main chapters:
Chapter 2 contrast agents
Chapter 3 animal disease models
Chapter 4 tomographic imaging modalities
Chapter 5 image post processing
1
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C O N T R A S T A G E N T S
The success of imaging is crucially dependent on the quality of the
acquired images. The image quality can further be described as a com-
bination of two contrast contributing factors, one being the difference
in brightness of two adjacent tissues, which is crucial for separating
two tissue types from each other and the second being their sharp-
ness, thus meaning the lack of blurring of the tissue interfaces.
Besides the successful usage of Contrast Agent (CA)s in both CT and
MRI, they only exploit the differences in the accumulation of these CAs
in certain tissues, without providing any specific targeting of certain
structures of interest, such as tumor cells. Nanoparticle based CAs on
the other hand, can be used for specific targeting, by modifying their
surface, e.g. by attaching a fragment of an antibody (tag) for recogni-
tion. Another way is to use macrophages as carrier of CA to specific
sites of inflammation, as shown in this thesis work.
2.1 contrast agents for computed tomography
CT is without doubts superior in spatial resolution, but by its na-
ture the contrast formation is related to the atomic number, Z of the
imaged materials, which therefore leads to a very poor contrast of
soft-tissue. A common technique to increase this contrast, thereby
enabling the usage of CT to image soft-tissue is the application of
contrast agents, such as contrast based solutions containing iodine,
barium or gold. Accumulated CT contrast agent will be directly visu-
alized in the acquired image.
In order to determine the X-ray absorption effects of a certain CA for
CT one can have a look at the X-ray Mass Attenuation Coefficient
(MAC) as a figure of merit, which can be interpreted as the effective
area per unit mass needed for absorbing a certain element, commonly
written in units of (cm2/g). Figure 1 shows the tabulated MAC for a
set of common CT CAs, such as zinc, barium, iodine, silver and gold.
3
4 contrast agents
Figure 1: The X-ray MAC of a set of common elements used in CT contrast
agents vs. the scanning energy. Data from source: [1].
2.2 contrast agents for magnetic resonance imaging
MRI contrast agents on the other hand are not directly visualized, as
for CT contrast agents. Instead it is the effect that the MR contrast
agents have on the varied water proton relaxation times that is used
for contrast enhancement.
Even though the source of contrast in MRI is of a different nature and
also more sensitive than CT, there is still a need to increase the con-
trast of targeted structures such as tumors or metastasis to further
facility their visualization.
The idea behind MR CAs is to shorten the T1 or T2 relaxation times
of the protons spins of water in tissue, in order to obtain a contrast
difference between two different tissues. CAs shortening the T1 relax-
ation time give rise to a positive contrast enhancement (bright images)
and are thus referred to as positive or T1-weighted CAs, whereas CAs
shortening the T2 relaxation time lead to a negative contrast enhance-
ment (dark images) and are therefore referred to as negative or T2-
weighted CAs. A more detailed description of the theory behind MR
is given in section 4.2.
Examples of positive CAs are paramagnetic metal complexes, such as
Manganese (Mn) (II) (5 unpaired electrons) and Gadolinium (Gd) (III)
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(7 unpaired electrons). Unpaired electrons have a magnetic dipole mo-
ment, that can interact with and shorten the T1 relaxation times of the
surrounding nuclei, such as the hydrogen atom, which is present in
water, making up around 60% of the body weight in a human adult
male [2]. More unpaired electrons of a CA implies stronger magnetic
relaxation effects on hydrogen [3].
Today clinically used MR CAs are based on complexes incorporating
Gd and Mn. The first clinical CA was a Gd based complex (Gd-DTPA),
developed in the early 1980s, FDA approved for intravenous admin-
istration in 1988 and sold under the trading name Magnevist r[4, 5].
Recent developments of CAs for MR based on the usage of nanopar-
ticles, such as e.g. Gd2O3 nanoparticles [6, 7, 8, 9, 10, 11] show that
they can be used to further increase the relaxivity of water, due to
the distribution of more Gd-atoms on a larger surface area, yet on a
small volume. where more Gd surface atoms are thus able to interact
with hydrogen protons. Ahrén et al. [12] and Hu et al. [13] reported
a water relaxivity increment of a factor of 2 per Gd atom for Gd2O3
nanoparticles, compared to Magnevist r.
2.3 selection and development of a multi-modal con-
trast agent for mri and ct
The usage of so called hybrid multi-modal contrast agent in non-
invasive image capturing techniques, such as CT and MRI, allows to
extract both complementary and synergistic information, thereby be-
ing able to make a more reliable comparison between the obtained
images, while as permitting easier diagnosis.
A dual-modal CA should have both MR and CT capabilities. Therefore,
a natural step would be to localize potential MR CA with a relatively
high X-ray MAC. Figure 2 shows the tabulated MAC for a set of com-
mon MR CAs. A potential contrast agent for dual-modal imaging in
both MR and CT is thus Gd based CA, with clear MR capabilities, as
described above, as well as a high MAC, thus suggesting its potential
use, as a CA also in CT. Also in comparison to common CT CAs, Gd
shows a very high MAC, as shown in Figure 1.
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Figure 2: The X-ray MAC of a set of common elements used in MRI contrast
agents vs. the scanning energy. Data from source: [1].
The CT capability of Gd has been clinically tested in some selected
studies [14, 15]. In the study by Bloem and Wondergem [14], two pa-
tients receiving an intravenous administration of Gd-DTPA, were first
examined with MRI, followed by examination with CT. The CT exam-
ination showed a high attenuation of concentrated Gd-DTPA in the
urinary bladder and renal system [14]. In a preclinical study by Gier-
ada et al. [16] the CT capability of gadolinium in the CA Gadodiamide
was investigated in porcine model, by injection of CA into a peripheral
vein in the hind limb of the pigs, where the contrast enhancement in
the aorta, pulmonary arteries, liver and kidneys were studied as an
effect of time after injection [16].
Other ways, to benefit from both MR and CT capabilities is to combine
an MR CA with an CT CA. Ahmad et el. [17] investigated the T1 MRI
and CT dual imaging capability of a hybrid CA, consisting of GdNPs
coated with various iodine compounds (IC). The IC-GdNPs showed
both stronger X-ray absorption and higher relaxivities, than commer-
cial CT or MR CAs [17]. Alric et al. [18] developed gadolinium chelate
coated gold nanoparticles for usage as a CA in both SR µ-CT and MRI,
which was confirmed by in-vivo scanning of rats and mice, injected
with the CA.
Marinescu et al. [19] instead used a negative T2 CA, based on Ultra-
small Superparamagnetic Particles of Iron Oxide (USPIO) to perform
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dual-modal CT-MRI cell tracking in a murine model of stroke, by in-
jecting USPIO loaded macrophages for homing of the brain lesion. The
results showed that SR µ-CT was capable of providing an accurate lo-
cation of the USPIOs, meanwhile in MRI a signal loss was observed,
that exceeded further away then the actual location of the USPIOs.
2.3.0.1 Sample preparation
In this thesis a combination of a clinically approved CT contrast agent
based on a suspension of Barium Sulfate (BaSO4) with Sorbitol (sugar
molecule), referred to as Micropaque rCT (originally a gastrointesti-
nal CA [20]) and a positive MR contrast agent based on Gadolinium
Oxide nanoparticles (GdO-NP) (hereinafter referred to as GdNP) [12]
were tested as intracellular contrast agents in an animal disease model
of asthma.

3
A N I M A L D I S E A S E M O D E L S
In general, any type of model has by definition characteristics that
resemble the target, but can however be different in other ways [21].
Diseases however are too complex to model with tissue models, cell
based assays or with computer programs. Due to the complex nature
of diseases they therefore need to be studied in living animals.
Human animal disease models are therefore today used to model a
human disease as accurately as possible on a preclinical level. Animal
Model (AM) experiments contribute to an increased understanding
of the involved mechanisms in a disease, although their capability
in predicting the treatment efficacy in followed clinical trials is still
quite controversial. [22, 23, 24]. Moreover, some critics also state that
the results obtained from using AMs can not always be translated to
humans, due to biological differences between the species and that
the results therefore are biased by the type of animal model used [25].
Representative AMs are therefore needed, with a well accepted and
studied disease type and an outbread laboratory strain [26].
Mouse models are commonly used to model human diseases, as they
are easy to handle, have a fast reproduction cycle and are cost ef-
fective, compared to other species. Mouse models are also based on
an inbreed mouse strain and therefore show low inter-sample varia-
tion for the parameter of interest. Furthermore, due to the small size
of mice, in comparison to the human, high end imaging strategies
need to be utilized, when studying a disease on a preclinical level,
as shown in Paper I and II. The obtained results about a disease can
then be translated to a clinical level where standard imaging devices
are used, as shown in Paper III.
3.1 experimental design
For both ethical and economical reasons it is important that the AM
experiments are well designed [21]. In order to make sure that the ex-
perimental plan complies with these ideas, one can follow the princi-
ple of the The three R:s (3R)s. The 3R states that if possible one should
1) Replace an animal model with a less sentient alternative, such as
a less complex invertebrates or use in vitro methods [21], 2) Refine the
experimental plan, in order to minimize any negative effects, such
as pain, suffering and distress for the animals [27] and 3) Reduce the
number of used animals, in order not to perform unnecessary repeti-
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tions of an experiment [21] or by obtaining more info from the same
number of animals [27].
3.1.1 Pilot studies & sample sizes
Pilot studies involving the usage of only one single animal are some-
times necessary to test the logistics of a given animal experiment.
The usage of a larger sample size, will permit the extraction of mean
and standard deviations, thus allowing the prediction of a likely re-
sponse, which can also be followed up with a statistical Power Analy-
sis, where the minimal sample size needed for detecting a significant
result with a low error [20] in an upcoming experiment can be deter-
mined [21].
3.2 selection of an animal disease model expressing in-
flammations
In order to test the both the capability and specificity of a dual-modal
contrast agents in both CT and MRI there was hence the need for a pre-
clinical case, in which important disease-related information could be
revealed, due to the presence and usage of contrast agents. As earlier
mentioned under Chapter 2, one way of performing specific targeting
of a contrast agent is to attach a fragment of an antibody to the sur-
face of nanoparticle based contrast agents. Another way of perform-
ing specific homing of CAs, is to let macrophages act as carriers of the
CAs. Macrophages are phagocytic immune cells (a type of white blood
cells) present in high numbers in tissue, where they are responsible
for a wide range of tasks including phagocytosis and clearance of
pathogens, microbes and cellular debris, as well as the upholding of
haemostasis. Furthermore, macrophages also have a wide range of re-
ceptors and surface molecules, and release mediators (e.g. cytokines),
which govern the inflammatory processes. Since macrophages play
an important role in inflammation and are capable of engulfing large
particles, such as CA, a proposed idea was therefore to use an animal
disease model expressing inflammation and then use macrophages
(subtype M2-macrophages) as carriers of intracellular contrast agents
to the sites of interests [28].
3.2.1 Animal model used in this thesis - an asthmatic mouse model
The chosen animal model to be investigated in this thesis work was
an asthmatic mouse model. Furthermore, asthma is a global burden
and affects around 329 million people worldwide [29]. There are dif-
ferent of asthma (acute and chronic) with several subgroups [30, 31].
The mechanism of asthma is not yet fully understood and only about
10% of the cases can be treated today. Asthma also has a strong in-
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flammatory component, which is preferably studied by MRI. Mizue
et al. [32] demonstrated that the lack of the migration inhibitory fac-
tor (MIF) in mice commonly used for studying asthma, lead to that
no asthma could be induced, thus suggesting that the migration of
macrophages plays an important role in the disease progression of
asthma.
Asthma only exists naturally in humans. Therefore in order to study
asthma in a mouse model, asthma-like symptoms need to be induced
artificially. This can be done using Ovalbumin (OVA), where also dif-
ferent severities of asthma can be induced [33]. The induction of an
asthmatic attack is further described in Paper II [34]. Asthma-related
anatomical changes are also very subtle and therefore require an ex-
ceptional good image quality and resolution, which can be offered by
SR µ-CT.
Moreover, since asthma is a complex disease, involving the immune
system and there are no in-vitro models mimicking the complex pro-
cesses of the immune system within the lung, the usage of an animal
model mimicking asthma is therefore required. With this in mind,
while following the principles of the 3Rs, the term Replace, was real-
ized by choosing a less complex invertebrate, such as a mouse model.
The Refinement term was considered, since the proposed OVA-induced
model, based on previous studies causes no pain and only slight
stress for the mice. Furthermore, the challenge with OVA may cause
asthma-like symptoms, such as short breath for a limited time for
the mice. The Reduce term was considered by one mouse per sample
group for the initial proof of principle studies and by extracting as
much information as possible from each mouse.
For this thesis work an OVA-induced allergic airway inflammation
model (mimicking human asthma [35]) was used, utilizing female
aged matched Bagg Albino - inbred research mouse strain (BALB/c)
mice. The mice were injected intranasally with either Barium Sul-
fate (BaSO4) or Gadolinium nanoparticles (GdNP) [12] loaded alveolar
murine macrophages [36], 24 hours after the asthma attack. Since the
strongest inflammation had been observed 48 hours after the asthma
attack, the biggest involvement of macrophages was expected at this
time point, which is why each mouse was sacrificed at this time point.
Herein-after the lung was inflated with air at constant pressure of 30
cm water column and each mouse was embedded in 1% agarose gel
confined inside a 30 ml tube, wherein after the lung was scanned a
structure in its normal state (in-situ) (in its natural condition inside the
mouse) with SR µ-CT and µ-MRI.
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Moreover, despite the known differences in transferring results from
a murine system to humans, this model is valid, since the central
signaling pathways are similar in both species. Furthermore, murine
macrophages have an average diameter of 10µm, whereas human
macrophages have a diameter of 20µm, thus implying a scaling ef-
fect by a factor of 2.
Figure 3: Scheme of the in-vitro cell loading approach followed by the intra-
cheal injection of macrophages in the mouse sample in-vivo.
3.2.1.1 Alveolar Macrophages as carriers of intracellular contrast agents
However, prior to injecting the cells into the AM there was the need to
optimize the cell loading efficacy of the given contrast agents, making
the contrast loaded cells distinguishable from other non-loaded cells
in SR µ-CT. The CT-slices in Figure 4 and 5 show an increased uptake of
BaSO4 loaded and Gd-loaded alveolar macrophages respectively, when
increasing the two parameters 1) culturing concentration of contrast
agent or 2) cell culturing time. The results showed an increased de-
tectability of BaSO4-loaded cells, meanwhile the detectability was less
for GdNP loaded cells.
Although the MAC (cm2/g) is higher for Gd than for Barium (Ba),
please see Figure 1, the crucial factor for the success of an intracel-
lular contrast agent in CT is dependent on the amount of material
taken up by the cell, where the uptake of more material increases the
detectability. The results above clearly show that the amount of up-
taken Ba is much higher then the amount of uptaken Gd. Therefore, in
order to be able to use GdNP as an intracellular contrast agent in this
case more precisely in SR µ-CT at an energy range between 17-22 keV
(for our purposes), there is the need to boost the cell uptake. In paper
IV the possibility that the increased cell uptake of Ba is related to the
immersion in Sorbitol is further investigated by capping/immersing
Sorbitol to GdNP. A high concentration of Gd is more optimal for CT,
but can if being to high lead to a black out of the positive T1-weighted
signal in MRI, due to an increased T2 effect of Gd at higher concen-
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trations. Therefore a trade off between an acceptable contrast in both
CT and MRI, directly related to the cell uptake of the GdNP needs to
be established. A second alternative for performing dual-modal cell
tracking in both CT and MRI is also based on the idea of mixing cell
colonies, separately loaded with either BaSO4 or GdNP, which is fur-
ther investigated in Paper IV.
Figure 4: Ba-loaded alveolar macrophages as a function of increasing 1) in-
cubation concentration of contrast agent or 2) incubation time.
Figure 5: Gd-loaded alveolar macrophages as a function of increasing 1) incu-
bation concentration of contrast agent or 2) incubation time. Please
notice that some minor accumulations of Gd-loaded cells give rise
to a higher contrast.
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a test of metabolic activity, to evaluate toxic effects
Apart from obtaining an optimal contrast in either CT or MRI, the most
important factor for performing cell tracking in an AM is to make sure
that the cell viability is acceptable. For Gd-based contrast agents it is
important to design the contrast agent so that no free Gd ions are
exposed to the living cells, since free Gd3+ ions are very toxic [37]. In
the commercial contrast agent Magnevist r, Gd is capped to the or-
ganic molecule diethylentriamine pentaacetic acid (DTPA), in order to
create a more biocompatible contrast agent, with the chemical name
Gd-DTPA, thereby reducing the possible toxic effects of any released
Gd ions. The effect that each contrast agent had on the cell viability
was assessed by a WST-1 cell metabolic activity test. Active and viable
cells will cleave tetrazolium salt WST-1 to a water-soluble formazan
dye with the help of the enzyme mitochondrial succinate-tetrazolium
reductase, where the measured absorbance of the dye is proportional
to the quantity of viable cells [38]. Such a WST-1 test was performed
in Paper IV on both the GdNP- and BaSO4-loaded macrophages.
4
T O M O G R A P H I C I M A G I N G M O D A L I T I E S
With every imaging modality comes both strengths and limitations
[20], related to the very technical nature of the given scanning system.
Furthermore, for non-invasive imaging, the modality should be cho-
sen with respect to the investigated parameter of interest, in order for
the study to be as effective as possible [20].
Preclinical research of small animal models also requires tomographic
imaging modalities with higher resolution, in order to be able to trans-
late the obtained results back to the clinic [20]. This has lead to the
need for dedicated preclinical tomographic imaging modalities (in-
cluding ways for improving the spatial resolution). Through so called
reversed translation of clinical tomographic imaging modalities such
as e.g. Positron Emission Tomography (PET), Single-Photon Emission
Computed Tomography (SPECT), Computed Tomography (CT) and
Magnetic Resonance Imaging (MRI) these techniques are today also
available for preclinical research [20].
Figure 6: Comparison of tomographic imaging modalities: CT, PET/SPECT
and MR, in terms of spatial resolution and sensitivity and their
ability to image anatomical structure, as well as physiological,
metabolic and molecular processes. Also the impact of using Con-
trast Agent (CA)s in CT and MRI is outlined.
The corresponding preclinical imaging modality to CT is referred to as
Computed Microtomography (µ-CT), where the spatial resolution can
be improved by the usage of a so called micro-focus X-ray tube, which
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is further explained under Chapter 4.1.2. Micro Magnetic Resonance
Imaging (µ-MRI) is the preclinical implementation of standard MRI,
where the limited resolution issues are improved by using dedicated
coils [20], with a size specifically fabricated with respect to the size of
the sample to be scanned.
4.1 computed tomography
The principle behind CT is related to the acquisition of a sufficient
number of planar projections (using either one or more detectors), at
different viewing angles of a given sample. For µ-CT however it is in-
stead the sample that is rotated, while the detector is fixed.
A projection image contains information about the attenuated X-rays
through the sample for a certain rotation angle. The acquired projec-
tions images (one for each angle of rotation) the 3D distribution of
the Linear Attenuation Coefficient (LAC) within the sample can be
calculated, through a process referred to as slice reconstruction [39],
which is further described in Section 4.1.5.
4.1.1 Production of Conventional X-rays
Conventional X-rays are produced by an X-ray tube, where a filament
(cathode) is heated using an electrical current, which will hence cause
electrons to be emitted. These electrons are then accelerated towards a
target material (anode), e.g. Tungsten, using an applied high voltage.
Furthermore, the incident electrons are abruptly de-accelerated when
they interact with the electrons in the anode material, wherein-after
X-rays are emitted.
4.1.2 Experimental setup of CT vs µ-CT
The difference in the experimental setup between a standard CT and
a µ-CT is mainly related to which one of the following components:
1) X-ray source (focal spot), 2) sample or 3) detector(s) that should
undergo a rotation, in order to permit the acquisition of projections
from different viewing angles. In the 4:th generation CT scanner the
sample/patient is surrounded with a fixed ring of detector elements
(can be seen as multiple detectors) together with a rotatable X-ray
source producing a fan/cone shaped x-ray beam. Where as for µ-CT
they the different viewing angles are obtained by rotating the sample.
The X-ray beam used for both normal CT and µ-CT is cone shaped.
However, the word micro in µ-CT is coming from the usage of a so
called micro-focus X-ray tube, which produces a much smaller focal
spot, with respect to the one obtainable in standard CT. A smaller fo-
4.1 computed tomography 17
cal spot gives the advantage of being able to reach higher resolutions.
Furthermore, a small focal spot also leads to partial coherent X-rays,
thus allowing to benefit from some limited Phase Contrast (PhC) ef-
fects. The obtainable resolution for a clinical body scan CT is in the
sub-millimeter range, and for a High Resolution Computed Tomogra-
phy (HRCT) around 80-90 µm/pixel, meanwhile resolutions down to
a few micrometers/pixel can be obtained using a µ-CT scanner.
Figure 7: Sketch of a µ-CT setup, showing the X-ray tube, sample, detector
(from left to right), including the work flow for slice reconstruc-
tion.
4.1.3 Synchrotron Radiation-µ-CT
Implementing the technique of µ-CT at an experimental end station at
a so called Synchrotron Light, allows the utilization of high intensity
monochromatic X-rays, with an X-ray range optimal for absorption
of low-absorbing samples, e.g. biological samples, together with PhC
effects of sample-edges, due to the high coherence of the near-parallel
X-ray bean, providing a resolution between 1-10 µm/pixel.
4.1.3.1 Production of Synchrotron Radiation
Synchrotron Radiation (SR) (electromagnetic radiation) is generated
when charged particles (e.g. a proton or an electron) moving close to
the speed of light are exposed to the presence of a strong magnetic
field, which will hence force them to follow a curved trajectory, at
which point SR is emitted perpendicular to the direction of the mov-
ing particles. SR can occur naturally in outer space, when astrophysi-
cal sources and the presence of a magnetic field are causing electrons
to accelerate radially along helical paths [40]. However, SR was first
discovered back in 1947 during a particle physics experiment using
the General Electric particle accelerator aiming to investigate the “un-
wanted energy loss" of the moving particles. This unwanted energy
loss was however shown to be related to the creation of SR. Soon later
the first dedicated synchrotron light sources were developed, with
the aim of using SR as a tool for revealing the inner structure of vari-
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ous materials. In the beginning these Synchrotron light sources were
however considered to be parasitic facilities, since accelerators were
usually built for conducting high-energy and nuclear physics exper-
iments. However, half a decade later we now have even the fourth
generation of Synchrotron Light Sources, being capable of producing
SR within the range from ultraviolet light to x-rays.
4.1.3.2 The principle and setup of a Synchrotron Light Source
The process of creating SR at a synchrotron commence with the gen-
eration of discretely separated electron bunches by an electron gun
(usually located inside the storage ring in a 3:rd generation synchrotron
source), wherein-after the electron bunches are initially accelerated by
the Linear Accelerator (LINAC). Here-inafter the electron bunches are
let to pass into the booster ring, which will allow the electron bunches
to be accelerated to their nominal working energy, wherein-after they
are finally injected into the storage ring (4), experiencing Ultra-High
Vaccum (UHV).
Figure 8: Scheme of a 3:rd generation Synchrotron Light Source including
a booster ring. The produced SR from a bending magnet is folded
into a narrow forward radiation cone, with continuous photon en-
ergies [41].
Well inside the storage ring the electron bunches are imposed to fol-
low a curved trajectory with the help of so called bending magnets,
which are located in between the straight positions of the storage ring.
The magnetic field present inside the bending magnets will cause the
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electrons to bend from their initial path, which will lead to an energy
loss of the electrons, represented by the a narrow angular cone of
emitted continuous SR [40]. Even brighter SR can also be generated
by so called insertion devices (Wiggler and Undulator), located in be-
tween the straight sections of the storage ring. Insertion devices are
capable of creating an alternating magnetic field, causing the elec-
trons to oscillate and radiate energy at every turn, thus creating dis-
cretly distributed SR.
The produced SR are the let to pass through a set of vacuum pipes, re-
ferred to as a beamline [40], after which they reach the experimental
hutch, which has been designed to host a given experimental tech-
nique (absorption, diffraction, etc.), with respect to the energy of the
incoming photons.
Furthermore, by using so called Radiofrequency (RF) cavities, which
are placed out at the straight sections of the storage ring, the energy
loss is synchronously restored to the passing electron bunches [41].
With time the current of the electron bunches slowly decays, due to
electron-to-electron collisions or collisions with any other molecules
present in UHV. In order to counter-act this the booster synchrotrons
can today be run in a so called Top-Up mode, where electron bunches
are injected periodically into the storage ring, thus making sure that
the electron beam current is kept at a constant level. This also implies
that the flux of the beam is kept at the same level, which is useful
when long scanning times are needed for a given sample.
4.1.3.3 Beamline setup for hard synchrotron X-rays tomographic imaging
The experiments performed during this thesis have been performed
at the SYnchrotron Radiation for MEdical Physics (SYRMEP) beamline
located 23 m far away from the source at the Elettra Synchrotron
Light Source in Trieste, Italy [42]. The source of the SR is a bending
magnet optimized for producing Hard X-rays in the energy region of
(8-35 keV) (optimal for X-ray imaging of biological tissue) [43], which
can be made monochromatic at a narrow energy bandwidth (∆E/E)
of 2 · 10−3, using a double-crystal Silicon monochromator, Si(1,1,1).
Furthermore the produced X-rays also have a near parallel geometry
[43], high flux, high brilliance and a high coherence, optimal for scan-
ning in the PhC mode. The available flux at the SYRMEP Beamline as a
function of the scanning energy, for various ring currents are shown
in Figure 10. Available scanning modes include Absorption (Abs), PhC
and diffraction imaging, utilizing scanning techniques such as planar
projection imaging, as well as tomographic imaging.
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For this thesis a Charge-Coupled Device (CCD) camera (Photonics Sci-
ence XDI-VHR) was used, which was coupled to a Gadox scintillator
screen [43], with a full frame of 2008 x 2672 pixels, a dynamic range
of 12-16 bit and a Field of View (FOV) of 18 x 12 mm2, a pixel size of
4.5 micrometers and binning 2x2, thus giving a final resolution of 9
µm/pixel.
Figure 9: Sketch of the SYRMEP Beamline with the implemented technique
SR µ-CT, including the work flow for slice reconstruction.
Figure 10: The flux at SYRMEP as a function of the energy, selected by the
monochromator, for various ring currents (modes of operation).
Please note that the peak of the flux-energy curve is shifted to-
wards lower energies and frequencies.
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4.1.4 Synchrotron Radiation-µ-CT vs conventional µ-CT
A SR-source offers; 1) high flux, which allows to filter to quasi-mono-
chromatic X-rays; 2) a near-parallel geometry of the beam and 3) a
large source-to-sample distance, in the range of 20-100 m, which in
combination create coherent X-rays. The coherence of the beam al-
lows to exploit the wave nature of X-rays, which is virtually not pos-
sible with conventional X-ray sources. For classical µ-CT on the other
hand the flux is much lower, thus resulting in much longer scanning
times and poor Signal-to-Noise Ratio (SNR).
4.1.5 X-rays interaction with matter and the attenuation of X-rays
X-ray photons penetrating through a sample will be attenuated, which
means that their initial intensity, I0 (number of photons) will decrease
to Ix, as a function of the sample thickness, x, according to the Beer-
Lambert law [44], which states that for a conventional (polychromatic)
X-ray beam, the detected X-ray intensity is given by [44]:
Ix =
∫
EI0(E) e
−
∫
lµ(x,E)dx dE,
where Ix is the X-ray photon intensity, as detected by a given detector
element (for a given row), and defined as the line integral (sum) of
all the Linear Attenuation Coefficient (LAC), also referred to as µ(x),
along the path, x of the X-rays and by the line integral of the photon
energy, E.
For a monochromatic X-ray beam the Energy-dependency is removed
and the Beer-Lambert law is thus reduced to the following relation-
ship:
Ix = I0 e
−
∫
lµ(x)dx
Furthermore, µ(x) is also affected by both the physical and chemical
composition of the scanned sample, as well as the sample density, ρ,
the atomic numbers, Z making up the scanned material [44] and by
the processes that occurs when X-rays interact with electrons in the
scanned material. The most important processes are the photoelectric
effect (absorption), inelastic scattering (Compton scattering), elastic
scattering (Thomson scattering and Rayleigh scattering) and pair pro-
duction.
A projection image represents the sum of all local attenuations, Ix
through the object along the path of the X-rays, as shown in Figure
11.
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Figure 11: Scheme showing the detection of attenuated X-rays passing
through a chest. The attenuation of X-rays is dependent on sam-
ple properties and thickness.
4.1.5.1 Imaging Modes
When X-rays interact with matter they undergo absorption, refraction
and diffraction, where the two subsequent ones are related to phase
shift effects. The complex index of refraction equation is stated below:
n = 1− δ+ iβ,
where the imaginary part β is responsible for the attenuation of the
sample, while as the term δ is the refractive index decrement related
to the phase-shift of the incident X-rays interacting with the sample
[45].
absorption imaging In conventional attenuation-based X-ray
CT-imaging the image-formation is based on the absorption of X-
rays, where µ(x) (LAC) is the reconstructed parameter in the CT-slice,
herein-after also referred to as µAbs(x).
This technique is well suited for scanning high absorbing samples,
which are very thick or consists of elements with a high atomic num-
ber, Z. However, using the Abs imaging method to scan soft matter,
which has a low Z, gives rise to poor contrast in the images, due to
poor absorption of the samples.
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phase contrast imaging However, if the sample-to-detector
distance is increased, while the utilized incident X-rays have a suffi-
cient coherency (as in the case when using SR X-rays or micro-focus
generated X-rays), the image-formation will apart from absorption,
also be based on a sample-induced phase-shift [46], occurring when
the X-rays are refracted on the borders between two sample compo-
nents (with different indices of refraction), such as the air-to-tissue
interface/edge inside the lung. This is referred to as Phase Contrast
(PhC)-imaging. The reconstructed slice will comprise three contribut-
ing parameters, thus being:
µRecon(x) = µAbs(x) + µPhC(x) + µMixed(x),
where µAbs is the map of the LAC of tissue (in this case), µPhC is
the map of the Laplacian of the tissue refraction index decrement,
which is the cause of the observed dark and bright fringes in the
reconstructed slice, as observed in Figure 13 on the borders/edges,
between two different materials, e.g. tissue and air. Furthermore,
µMixed(x) is an artifact related to the overall variations of µAbs and
µPhC, which will hence lead to a distortion of the local structure of
the imaged lung sample [45]. The estimation of the µRecon(x) for tis-
sue will therefore be slightly inaccurate [45].
Furthermore, PhC is optimal for scanning soft matter, i.e. samples with
a low Z, which are poor absorbers of X-rays [47]. Wu et al. [45] es-
timated δ and β values for biological tissues, where it was further
shown that δ is around 1000 times stronger than β in the X-ray range
of 10-100 keV [48, 49]. This also implies that the difference in terms
of δ between two given tissues are larger, than the differences in β,
thus suggesting that X-ray based PhC-imaging is more sensitive, than
standard Abs-imaging [50, 51, 52, 48, 49, 53]
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Figure 12: Illustration of the diffraction of X-rays for Absorption vs. prop-
agation based imaging, for various sample-to-detector distances,
z, where λ is the X-ray wavelength and d is the size of a sam-
ple structure orthogonally to the beam direction [47]. Allowing
the diffracted X-rays to propagate the short altered distance z
beyond the sample a Fresnel diffraction will occur, under the cir-
cumstances that z ∼ d2/λ [50, 47]. This is referred to as in-line PhC
imaging method [47].
phase retrieval However, if the PhC-effects are to strong, they
will prevent further segmentation and quantitative analysis steps [54].
By a applying a so called Phase Retrieval algorithm on the projection
images followed by a standard reconstruction algorithm, e.g. Filtered
Back Projection (FBP), a slice that predominately shows the δ-term of
the complex index of refraction, without any enhanced phase-effects
can be obtained [55, 54]. Single distance Phase Retrieval (PhR) algo-
rithms require a regularization parameter [46], herein-after referred
to as the δ/β-parameter, in order to more precisely reduce the phase
effects from a given sample. The delta-to-beta parameter can be ob-
tained experimentally by scanning a sample at multiply distances and
then estimating the δ and β values at each distance. The delta-to-beta
ratios for various biological tissues are also available in certain look-
up tables [56, 57] based on data found in Henke et al. [1] Hubell et
al. [58] and White et al. [59]. Furthermore, in Paper I, it was demon-
strated that by suppressing phase-effects, as done by using PhR, a
more precise grey level thresholding of the slices can be performed.
Wu et al. [45] also stated that for more accurate characterization of
tissue, the acquired projections should be used to reconstructed two
different data sets, one based on only the linear attenuation coefficient
of tissue, β and the other one based on the tissue refraction, δ.
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Figure 13: Line profile for each considered air-to-tissue interface for the
given imaging modes Abs, PhC and PhR.
4.1.6 Image quality
The quality, Q of an image in CT is affected by mainly 4 factors, the
spatial resolution, s, the image noise, σ, the dose, D and the slice
thickness, z through the following relationship:
Q ∝
√
1
s3·σ2·z·D
where a high Q factor implies better image quality. According to this
expression there is an interplay between the three imaging parame-
ters, spatial resolution, the image noise, the dose, and the slice thick-
ness.
Figure 14: Illustration of the trade off between SNR, Resolution and Scan
Time/Dose in CT
When scanning biological matter it is often crucial to reduce the scan-
ning time and hence the delivered dose, in order to avoid x-ray dam-
age. This can be achieved by increasing the amount of detector ele-
ments used for forming 1 pixel in the obtained image, also referred
to as the binning of the detector. A binning 1x1 means that 1 detector
element on the detector is corresponding to 1 pixel on the readout im-
age. By increasing the binning from 1x1 detector elements to 2x2, the
average signal of 4 detector elements will instead be used to record
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the grey value of 1 pixel in the readout image, as shown in Figure
15. This will hence decrease the final spatial resolution, as well as
the noise, the slice thickness and the scanning time and the delivered
dose, which might be preferable. From the above relationship it can
be shown that by decreasing the spatial resolution with a factor of 2,
while maintaining the same noise, image quality and slice thickness,
the delivered dose and hence also the scanning time are reduced with
a factor of 8.
Figure 15: Illustration of binning 1x1 and 2x2 of a detector.
Figure 16: Shows a comparison of two lung data sets from A) a mouse
scanned in Abs mode using an eXplore Locus SP (GE HealthCare)
(MPI, Göttingen, Germany), pixel resolution = 26 µm and B) a
mouse scanned in PhC mode at the SYRMEP Beamline and after
applied PhR, pixel resolution = 9 µm.
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4.2 magnetic resonance imaging
4.2.1 NMR Background
The Electromagnetic Radiation (EMR) phenomena entails that if a pro-
ton (or other nuclei) with a spin is placed inside a magnetic field,
wherein-after EMR is sent onto them, the protons will absorb the EMR
and re-emit the EMR, which will hence induce a voltage in a wire (re-
ception coil) that is placed around the protons.
In order for a nuclei to give rise to an EMR signal, it needs to be
EMR-active. Isotopes with an odd number of protons and/or neutrons
have a magnetic moment and angular momentum, thus meaning a
non-zero spin and are hence EMR-active, while nuclides with an even
number of protons and neutrons have a total spin of zero and are
thus EMR-inactive. Examples of EMR-active nuclei are 1H, 3He, 13C,
15N, 17O, 19F, 23Na, 31P and 129Xe.
Figure 17: Magnetic Properties of nuclei for odd and even mass numbers
Each type of nuclei has an independent Nuclear Magnetic Resonance
(NMR) (footprint) signal, where the characteristic resonance frequency
(Larmor frequency) of the nuclei is proportional to the applied mag-
netic field. The Larmor frequency (frequency of precession) is given
by the Larmor equation as: f0 = γ · B0, where f0 is the Resonant Fre-
quency, γ is the Gyro-magnetic Constant and B0 the Static Magnetic
Field (in Tesla).
4.2.2 Net magnetization
NMR-active nuclei present inside an applied magnetic field, B0 will
either align its magnetic moment along the direction of the magnetic
field B0, referred to as the +1/2 spin state (of the proton) or in the
opposed direction of B0, thus meaning a -1/2 spin state. In a large
population of hydrogen atoms, such as the tissue in the human body,
slightly more than half of them will align themselves with the +1/2
spin (lower energy level) and the rest with the -1/2 spin (higher en-
ergy level). If enough amount of protons are aligned in the lower
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energy state, the spin excess or net magnetization, M is big enough
to be detected.
Figure 18: Illustration of the net magnetization.
When a proton in a spin state +1/2 is exposed to EMR by an RF-pulse
(perpendicular to the direction of the B0 field) with a frequency cor-
responding to its precessional frequency (Larmor frequency), it will
flip to the higher energy level of −1/2 spin state, thus undergoing an
excitation, creating a resonance condition where the proton will start
to exhibit precessional motion with a characteristic frequency around
the vertical axis aligned with the direction of B0.
Figure 19: A) An average proton inside a magnetic field aligned with B0, B)
RF-pulse will cause the proton to precess around B0 and C) when
the RF-pulse is shut off an RF-signal will be produced.
The source of the MR-signal is the net magnetization, M. In equilib-
rium, M is aligned with B0 and no precession around B0 is present,
thus meaning that no EMR is emitted. When an RF transmitter coil
produces an RF pulse that is sent onto the protons, this will cause M
to be tipped down from its vertical position onto the transverse plane,
which will cause the protons to start to precess around B0, thereby
inducing a voltage in a very sensitive RF-coil (via Faraday’s law of
induction) placed in the vicinity of the sample.
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4.2.3 Relaxation
4.2.3.1 Free Induction Decay
Once the RF transmitter coil is turned off the protons will start to re-
emit the absorbed energy, meanwhile the signal will start to decay,
which is called a Free Induction Decay (FID). The initial amplitude of
the FID signal is determined by the Magnetization vector, Mxy (trans-
verse component around the z-axis and perpendicular to B0 ), which
has been tipped onto the xy-plane, where the highest amplitude is
obtained at the flip angle 90 °, where sin(90) = 1, directly after the
RF-pulse has been switched off. Furthermore, the rate of decay is de-
pendent on the T2 time constant.
Figure 20: Illustration of the processes Free induction decay, T1 recovery, T2
decay and T2 star decay in MRI.
transverse relaxation (t2) T2 relaxation is the process which
occurs when the transverse component of the magnetic vector, Mxy
decays to the value zero, due to spin-dephasing, cause by random
spin-spin proton interactions, where the small magnetic fields from
neighboring protons effect each other.
30 tomographic imaging modalities
Figure 21: T2 decay signal. The T2 time constant is the time it takes for the
transverse magnetization to decay to a value of 1/e = 0.37 = 37%
of M0, following the formula Mz =M0 · e−t/T2 .
t2 star relaxation (t2*) T2* (T2 star) relaxation is due to both
T2 relaxation and due to field inhomogeneities of the static mag-
netic B0 field, magnetic susceptibilities and chemical-shift artifacts. A
rephasing can however be performed by using a chain of 180 degrees
flip RF-pulses, which will then generate T2* echoes. These echoes will
however have a lower and lower amplitude (for each repetition), due
to the T2 decay effects.
longitudinal relaxation (t1) T1 relaxation is the recovery
of the longitudinal component of the magnetic vector, Mz along the
z-axis (direction of the B0 field). The T1 process occurs when protons
(excited from the RF-pulse) spin around and return to their lower en-
ergy state at which they generate small magnetic field fluctuations
also affecting surrounding protons, leading to the restoration of the
longitudinal magnetization vector, Mz.
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Figure 22: T1 recovery signal. The T1 time constant is the time it takes for
the longitudinal magnetization to reach (1− 1/e) = 0.63 = 63%
of the M0 value, following the formula Mz =M0 · (1− e−t/T1).
4.2.4 Image contrast
Figure 23: Illustration of the contrast formation as a function of the Time to
Repeat (TR) and Time to Echo (TE)
4.2.4.1 T2 contrast
T2 contrast (or T2-weighted) images are produced based on the dif-
ferent T2-relaxation times of tissues inside the scanned sample. T2
contrast is achieved by scanning with Long TR, in order to minimize
T1-weighting and with Long TE, in order to enhance the T2-weighting.
The obtained MR-signal is proportional to the product of the proton
density and the inverse exponential of TE divided by T2, according to
the following expression: MRI ∝ p0 · e−TE/T2 .
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4.2.4.2 T1 contrast
T1 contrast (or T1-weighted) images are produced based on the dif-
ferent T1-relaxation times of tissues inside the scanned sample. T1
contrast is achieved by scanning with Short TR, in order to enhance
T1-weighting and Short TE, in order to minimize the T2-weighting.
The obtained MR-signal is proportional to the product of the proton
density and the factor 1 subtracted with the inverse exponential of TR
divided by T1, according to the following expression:
MRI ∝ p0 · (1− e−TR/T1).
4.2.4.3 PD contrast
Another type of contrast apart from T1 and T2 contrast is the Proton
Density (PD) contrast, which is based on the amount of hydrogen
atoms (water content) present inside the scanned sample. PD con-
trast is achieved by scanning with Long TR, in order to minimize
T1-weighting, thus allowing a complete recovery of the longitudinal
magnetization and Short TE in order to minimize the T2-weighting.
The obtained MR signal is directly proportional to the proton density,
according to the following expression: SMRI ∝ p0.
4.2.5 Encoding the MR-signal
In order to spatially encode the MR-signal to a certain voxel in the
image space, three different types of orthogonal magnetic field gradi-
ents, (that can be switched on and off), one for each spatial dimension
(x,y,z), are needed [60, 61, 62], thus being A) a frequency encoding
gradient, Gx, B) a phase encoding gradient, Gy and C) a slice selec-
tive gradient, Gz. In order to produce such linear varying magnetic
fields, a hardware piece referred to as a gradient coil is needed. For
readout of the generated MR-signal a receiver coil is used. Both coils
are placed around the sample to be scanned.
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Figure 24: Frequency, phase and slice selective encoding gradient. Please no-
tice that bones can in general not be visualized with T1-contrast,
due to the very low amount of water content in bones.
4.2.5.1 Frequency-encoding
Frequency-encoding of the spins is performed by applying a constant
gradient Gx, also referred to as Gread, along the x-direction of the
image space, during the readout of the MR-signal. This will cause the
spins to start precessing at different resonance frequencies, related
to their position along the applied frequency-encoding gradient. The
spins are thereby frequency-modulated along the readout direction.
The resonance frequency of the proton spin is hence proportional to
the position of the spin, as given by the following formula:
ω0(x) = γ · (B0 +Gread · x)
where GFE is the frequency encoding magnetic field gradient at the
given position x.
4.2.5.2 Phase-encoding
Phase-encoding of the spins is obtained by applying a constant gradi-
ent, Gy, also referred to as Gphase, along the y-direction of the image
space, during a specific time frame (pulsed), prior to the readout of
34 tomographic imaging modalities
the MR-signal, which is repeated with different phase-encoding steps,
Nphase. When the phase-encoded gradient is turned on it will cause
the spins to start precessing at different resonance frequencies, related
to their position along the applied phase-encoding gradient (similar
to Frequency ending), and when the gradient is turned off the spins
will start to precess with the same frequency as proportional to the
external magnetic field, B0, but with different phases, during a given
time point (dephasing).
Furthermore, protons in the same row perpendicular to the direction
of the gradient will precess at the same phase. The received MR-signal
for each row will be slightly out of phase. For an image with N num-
ber of rows, N number of acquisitions using different phase encoding
gradients, Nphase will be performed. The spins are thereby phase-
modulated along the phase-encoding direction.
4.2.5.3 Slice encoding
Slice encoding is achieved by applying a combination of a constant
gradient, Gz, also referred to as Gslice, along the z-direction of the
image space, together with an RF-pulse containing a narrow band-
width of particular frequencies around the Larmor frequency, thereby
only exciting spins that resonate with the same frequencies as present
within the bandwidth of the applied RF-pulse. The position of the
slice is defined by the central frequency of the RF-pulse, meanwhile
the slice thickness is determined by the bandwidth of the RF-pulse.
The formula for the slice selection of the Larmor frequency is given
by:
ω0 = γ · (B0 +Gslice · z)
where GSS is the magnetic gradient field at the given slice position z.
4.2.6 Imaging parameters
The signal in MRI is proportional to the B0 squared over absolute tem-
perature, SMRI ∝ B20/T . The noise σ in MRI comes from two different
sources 1) noise from the resistance coil, where σ ∝ B1/20 and 2) noise
from the body (sample), where the σ ∝ B20. Moreover, for big sample
(such as humans) the noise increases proportionally to B0 as earlier
stated, while as for smaller samples (such as mice) the noise is more
limited by the performance of the coil and other other components in
the detection chain of the system.
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4.2.6.1 Signal-to-Noise Ratio and relationship to resolution and scan time
The Signal-to-Noise Ratio (SNR) is defined as the quote between the
signal and noise and is explained in general under Section 5.1. For
MR the SNR is dependent on the noise coming from both the coil and
the scanned sample as given by the following expression:
SNRB0 =
SMRI
σ =
SMRI√
σ2coil+σ
2
body
=
B20√
α·B1/20 +β·B20
where the α-parameter is related to the coil characteristics, such as
number of turns, conductivity and filling factor, while as β is related
to the size and conductivity of the sample. Furthermore, both the α
and β parameter are also dependent on the absolute temperature.
The Signal-to-Noise Ratio (SNR) increases with increasing B0 and the
proton density, ρ inside the tissue of the imaged sample, as stated
below:
SNR ∝ B0 · ρ.
As earlier stated the SNR is also affected by the design of the RF coil
and is inversely proportional to the size, d of the reception coil. The
SNR can thus be further maximized by using a coil that optimally sur-
rounds the volume of the imaged sample, since n very small elements
are used for signal detection.
Furthermore, the SNR is also affected by imaging-sequence parame-
ters, thus being the image resolution and scan time. More precisely
the SNR is directly proportional to the 3D imaging resolution and to
the square root of the scan time, according to the following formula:
SNR ∝ 3DImagingResolution ·
√
ScanTime.
Furthermore, the resolution (pixel size) in each direction (x,y) is de-
pendent on the Field of View (FOV) and the number of frequency, Nx
and phase encoding steps, Ny, according to the formula below:
FOVdirection = Resolutiondirection ·Ndirection.
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Figure 25: Relationship between the k-space, image resolution and FOV.
Moreover the scan time is dependent on the Number of Averages,
NAVG, corresponding to several collections of each line in the k-space,
as well as the Number of phase encoding steps and the read out time.
The SNR dependency can thus be written as:
SNR ∝ ∆x ·∆y ·∆z ·√NAVG ·Nx ·Ny ·Nz ·∆t
where ∆x ·∆y ·∆z is the product of the image resolution in each di-
rection, xyz, Nx ·Ny ·Nz is the product of the frequency and phase
encoding steps and ∆t is the time for reading one pixel in the x-
direction of the k-space. The expression can also be rewritten using
Tread = Nx · ∆ t, where Tread refers to the time it takes to read an
entire line in the x-direction.
SNR ∝ ∆x ·∆y ·∆z ·√NAVG ·Ny ·Nz · Tread
According to the expression above there is an interplay between the
three imaging parameters, SNR, Resolution and Scan time. The SNR
can be increased by either decreasing the spatial resolution (which is
equal to increasing the FOV, while keeping the same image matrix) or
by increasing the scan time.
4.2 magnetic resonance imaging 37
Figure 26: Illustration of the trade off between SNR, Resolution and Scan
Time in MRI.
For this thesis work MR experiments were conducted with a 3D spin-
echo (3DSE) imaging sequence using the following parameters: FOV
26x26x26 mm, imaging matrix 128x128x128, TE 2 ms, TR 200 ms, num-
ber of averages 2, and total scan time 2 h, with an isotropic image res-
olution of 203 micrometers/pixel, using a 9.4 Tesla (400 Mhz) µ-MRI
scanner at the Jošef Stefan Institute in Ljubliana, Slovenia. Further-
more, MRI-imaging with both short TE and TR, correspond to T1-
weighted imaging. Figure 27 shows an MR slice of a scanned mouse
lung sample.
Figure 27: Shows the lung data for a mouse scanned according to the proto-
col mentioned above, pixel resolution = 203 µm.

5
I M A G E P O S T P R O C E S S I N G
After acquiring an image the next natural step is to apply various
image processing steps, including e.g. segmentation, in order to cre-
ate a more enhanced image, which will facilitate further visualization
and/or image analysis steps. Visual inspection in 3D is useful for
finding certain image details, which might otherwise be missed if
only assessing the data in 2D.
Image analysis can be used to support the observations of the visual-
ized data, based on quantifiable numbers. The goal of image analysis
is to extract numerical values from the images, through the applica-
tion image parameters that quantitatively describe various properties
or structures in a given image. Automated quantitative image analy-
sis ensures both objective and reproducible results [20].
Multi modal imaging by e.g. CT and MRI, followed by image fusion
allows the extraction of synergistic information, by both visual and
quantitative analysis, which will lead to more accurate and reliable
diagnosis [20].
5.1 image quality
The quality of an image is directly related to the physical property
being imaged with a given modality [20], as well as to the scanning
parameters of the system, such as the pixel size and scanning time.
The quality in an image is commonly quantified with 1) Signal-to-
Noise Ratio (SNR) - which is defined as the mean intensity of the
investigated object, divided with the standard deviation of a homo-
geneous region and 2) the Contrast-to-Noise Ratio (CNR) - which is
defined as the difference in mean intensity between two objects, di-
vided with the standard deviation of a homogeneous region [20].
SNRa,c =
µ(a)
σ(c)
CNRa,b|c =
µ(a)−µ(b)
σ(c) = SNRa,c − SNRb,c
For improved image quality, SNR and CNR should in general be max-
imized, if feasible, with respect to the given scanning conditions [20].
However, in parallel to maximizing the SNR and CNR, it is also impor-
tant to consider the sharpness of the image. By applying a median
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filter on an obtained slice, the SNR and CNR can easily be maximized,
but such a procedure will introduce blurring of the sample edges. In
Paper I both the CNR and blurring effects are evaluated for phase-
retrieved in-line phase contrast images of a mouse lung and com-
pared to conventional Propagation-based imaging (PBI) images.
5.2 segmentation techniques
The ability to successfully segment sample components from each
other is crucial for any further quantitative analysis or 3D-rendering.
One of the most common segmentation approaches is simple inten-
sity thresholding [63], where the components are segmented based
on their grey level value, proportional to their LAC. The utilization of
grey level thresholding becomes challenging however, when there is
to much noise in the images or when the sample components experi-
ence similar Linear Attenuation Coefficient (LAC) values.
A direct threshold based segmentation of the lung envelope also con-
taining CAs presents some further challenges, since the there is an
overlap of the LAC values, in between 1) lung tissue and other tis-
sue present in the chest region, 2) air in the lung and air present
below the skin and and 3) contrast agent present inside the lung enve-
lope and rib cage bones. Figure 28 shows a comparison between grey
level thresholding of Contrast Agent (CA) and lung tissue for Absorp-
tion (Abs), Phase Contrast (PhC) and Phase Retrieval (PhR) simulated
images of the chest region. It is shown that the specified threshold op-
timal for segmenting the contrast agent, also segments rib cage bones
(Figure 28 ABC) and PhC edge effects around the trachea air/tissue
interface for the PhC image in B). Furthermore, the specified thresh-
old optimal for segmenting lung tissue, also segments other tissue in
DEF).
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Figure 28: ABC) shows the effect of the an appropriate threshold for seg-
menting CA present inside the lung and DEF) the effect of an
applied threshold for segmenting lung tissue for simulated Abs,
PhC and PhR images of the chest region.
Therefore, in order to only segment the lung envelope and CA present
inside the lung, there is hence the need for more advanced segmen-
tation techniques. Examples of more advanced segmentation tech-
niques are gradient based methods [64], level set and active contours
[65], graph based approaches [66, 67] and region growing [68, 69].
However, the final choice of segmentation technique also depends on
sample specific properties, in this case e.g. lung disease alterations
and acquisition related parameters, e.g. CNR, resolution and the uti-
lization of contrast agents.
For the segmentation of the lung envelope, a region growing algo-
rithm [70] was applied, including the distribution of so called seeding
(starting) points [71] inside the lung envelope, that continue to grow
until no more neighboring pixels with the specified grey level range
of air-to-soft-tissue can be located.
The applied region growing procedure was followed by the applica-
tion of standard image processing procedures and final thresholding,
which was proven to be successful for segmenting both the lung en-
velope, as well as the CA present inside the lung, as further described
in Paper III.
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The proposed image processing scheme is further explained in Figure
29, where simulated images of the chest region have been used. Step
1) shows segmentation step using region growing, in order to only
segment the lung envelope. In step 2) a hole fills algorithm is applied,
in order to fill the void space of the CA. The obtained mask is the
multiplied with the original image in step 3) giving a masked image
only containing the lung envelope, which is used for thresholding the
air, tissue and CA components in step 5B). In side step 4) the original
image was subtracted with the masked image of the lung envelope
and the obtained imaged was used the threshold the bones of the
rib cage in step 5A). In paper III it was also shown that this image
processing scheme also could be translated to clinical Abs images of
the lung, as well as on µ-MRI images of the lung, as shown in Paper V.
Figure 29: Outline of image processing scheme for separating the lung enve-
lope from other components with similar attenuation coefficients
in the chest region.
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5.3 volume rendering
Following the scheme outlined in Figure 29 the four segmented com-
ponents in step 5) air, tissue, contrast agent and ribs can be success-
fully rendered in 3D, thereby emphasizing the effects of the asthmatic
attack, compared to the healthy control, as shown in Figure 30. In
this thesis work the VG Studio 2.2 software (Volume Graphics GmbH,
Heidelberg, Germany) was used for 3D-rendering.
Figure 30: Volume rendering of acute asthma (AA) and blank (BL) showing
air (cyan), soft-tissue (red) and BaSO4 loaded macrophages (yel-
low). For AA the BaSO4 loaded macrophages are found in close
vicinity to the tissue component, showing airway wall thickening,
which is a common hallmark of asthma. Image from Larsson et al.
[72]. Reprinted with permission. (Copyright 2015 IOP Publishing
Ltd).
5.4 selection of volume of interest
Image analysis, as further described under Section 5.5, is commonly
performed on smaller, yet representative sub-volume of the sample,
referred to as Volume Of Interest (VOI), instead of analyzing the en-
tire, in this case segmented lung data set.
VOI selection is usually done on the original data set, prior to seg-
mentation. For the given lung data sets, the positioning of a VOI in
the lung envelope (Figure 31), would thus reduce the segmentation is-
sues earlier explained in Figure 28, from a four-component to a three-
component classification process, where the different components are
made up by 1) Air, 2) Tissue, 3) Contrast agent, 4) Rib cage bones and
N) any other component in the chest region, with a similar LAC (grey
value) as any of the former components.
Both segmented VOIs or entirely segmented data sets can be used for
further quantitative analysis, as addressed under Section 5.5. How-
ever, some quantitative parameters, such as e.g. skeleton analysis are
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required to be applied directly on the VOIs, instead of on the entire
data set, which is related to implementation details of the parameters
in mind.
Figure 31: Volume rendering of acute asthma (AA) and blank (BL) showing
soft-tissue (red) and BaSO4 loaded macrophages (yellow). Selected
positions of VOIs are indicated with white squares. Image from
Dullin, dal Monego, Larsson et al. [34]. Reprinted with permis-
sion. (Copyright 2015 International Union of Crystallography).
Moreover, a representative VOI should be positioned far away from
the sample borders, in order to avoid the selection of non-sample
specific parts. The VOI should also have a sufficiently large size, in or-
der to successfully represent the features of the larger sample, thereby
making sure that the extracted quantitative parameters are stable and
not being affected by the size of the chosen VOI. This concept is also
referred to as macroscopic homogenization [73] or representative ele-
mentary volume [74]. A key principal when defining the size of a VOI
is to choose a size that is at least one order of magnitude larger than
the characteristic size of the investigated structures of the sample [75].
Furthermore, where applicable it is is also recommended to extract
more than one VOI, which have been spread out in a non-overlapping
manner over the sample, thereby obtaining both a mean and a Standard
Deviation (SD) for the analyzed parameter [75]. This will allow to eval-
uate both the size and position dependency of the VOIs, in relation to
the quantified results, where a too low SD might suggest that 1) the
VOI size is too small in comparison to the structural size of the sample
components or 2) the VOI size is instead too large, thus resulting in
minor changes of the extracted mean values, where any differences
would be leveled out [75]. Each VOI is used for extracting a set of quan-
titative parameters. The optimal VOI size might also vary slightly for
each considered quantified parameter. Therefore, it is important to
chose a VOI size that provides the best trade off for all the quantified
parameters [75].
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5.5 quantitative & statistical image analysis
For certain images with complex structures details, visual inspection
can often be quite challenging, both 2D- and 3D-based one. In such
cases quantitative analysis of user selected Volume Of Interest (VOI)s
can often be a helpful tool, in order to differentiate between two sam-
ples. Quantitative analysis can of course also be used side by side, to
support or confirm the observed visual results.
Examples of common quantitative image parameters are e.g. Percen-
tage Volume (PercVol), Structure Thickness (StTh), Structure Separation,
Structure Number, degree of anisotropy, fractal dimension and skele-
ton analysis. However, when working with preclinical or clinical im-
ages, such e.g. images of the lung it is important to chose quantitative
image parameters that can easily be understood by clinicians and ex-
perts in the field, in this case in the field of lung imaging [72]. Such
chosen parameters are therefore the PercVol and StTh, where the lat-
ter is shown in 32. The PercVol is calculated as the ratio between the
amount of voxels corresponding to e.g. the soft-tissue divided by the
total amount of voxels present in the given VOI. The computation
of the StTh is based on the Parallel plate model [76], where complex
sample structures are approximated a network of plates, which mean
thickness is the StTh of the quantified component.
Figure 32: Selected VOIs from Figure 31 for acute asthma (AA) and blank
(BL). White double arrows show StTh (from left to right) for Air,
BaSO4 loaded macrophage clusters and Soft-tissue. Modified im-
age from Dullin, dal Monego, Larsson et al. [34]. Reprinted with
permission. (Copyright 2015 International Union of Crystallogra-
phy).
The two above mentioned parameters were quantified with the Pore3D
[77, 78] software library for 3D quantitative analysis, developed by the
SYRMEP group (Elettra, Italy). Here in after, the quantified parame-
ters were evaluated with statistical analysis, in order to confirm if or
not there were any statistical differences in between the samples. Sta-
tistical analysis was performed using the MINITAB software (Minitab
Ltd; Coventry, UK), as shown in Paper II, III and V.
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5.6 image registration
When scanning a sample with two different modalities, in this case CT
and MRI or when performing a repeated scan of a sample at separate
time points with only one modality, slight variations in the sample
acquisition orientation (x,y,z) can thus be expected. This opens up
the need for image registration of the sample data, in order to find a
spatial correspondence between the images. Registration of images
from a sample scanned by two modalities, is referred to as intra-
subject multi modality co-registration [20], meanwhile the registration
of images from a sample scanned with the same modality, is referred
to as intra-subject single modality co-registration. Furthermore, modal-
ity related differences of the imaging capturing parameters, such as
the image size, image resolution and image quality, also limit further
multi modality image registration [20]. Therefore, in order to facili-
tate the registration of the MRI slices with the CT slices, some prior
image processing can be performed.
For the lung samples scanned with both SR µ-CT and µ-MRI during this
thesis work, there was hence also the need for some further image reg-
istration, with the goal of extract synergistic information from fused
images. In order to realize this idea, an image processing scheme was
outlined, as further described in Paper V, where the MRI slices were
first upscaled to the same image size as the CT data. Secondly the rib
cage bones in the CT images were thresholded and set to the same
grey level as the surrounding tissue, in order to make the CT data
more similar to the MRI data, since T1-weighted images do not allow
the visualization of bones, due to their very low water content. Figure
33 shows the outline of the hereby described image processing and
registration methodology, here using simulated CT and MRI lung data.
When it comes to selecting a suitable image registration algorithm,
there are two main categories 1) rigid body transformations, which
assumes no shape changes of the sample structures, in between the
compared images and 2) non-rigid affine body transformations, suit-
able for performing image shearing of the compared images, where
structural shape changes may be present [20].
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Figure 33: Image processing and registration scheme of CT (colored in red)
and MRI (colored in green) lung images.
In this thesis work a fully automatic elastic/affine image registration
algorithm, developed by Sorzano et al. [79] was used, since the lung
showed some shape differences in between the CT and MRI data sets,
as further described in Paper V.
Figure 34 shows an enlargement of the fused MRI and CT lung data
set (both non-registered and registered), which is used to for finding
synergistic information [20], as demonstrated in Paper V.
Figure 34: Image fusion of lung images of CT data (in red) and MRI data
(in green) of a) non-registered data and b) of elastically regis-
tered data. Please notice the improved overlapping of the lung
envelopes visualized by both CT and MRI in b).
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S U M M A RY O F PA P E R S
6.1 paper i :
Objective:
To investigate the potentials and benefits of single-distance phase re-
trieval lung imaging, using in-line free propagation Phase Contrast
X-ray Computed Tomography (PCX-CT).
Materials and Methods:
In-line free propagation SR Phase Contrast X-ray Computed Tomogra-
phy (PCX-CT) was performed of an in-situ mouse lung sample at three
different sample-to-detector distances, being 7, 30 and 100 cm at an
energy of 22 keV, spatial resolution of 9 µm, Field of View (FOV) of 18
mm x 12 mm, 1800 projections. In order to reconstruct an image with-
out edge effects, with predominantly the real part (delta-distribution)
of the complex refraction index, a single-distance in-line Phase Re-
trieval (PhR) algorithm based on the Transfer of Intensity Equation
(TIE) equation was applied, with a delta-to-beta ratio set to 1950 (calcu-
lated value for standardized lung tissue). Phase-retrieved slices were
also compared with Propagation-based imaging (PBI) slices (also re-
ferred to as Phase Contrast (PhC) slices), where no PhR had been ap-
plied. In order to extract info about the image quality a set of param-
eters were extracted, thus being the Contrast-to-Noise Ratio (CNR)
between the air and soft-tissue, the Edge-Enhancement Index (EEI),
based on a line profile applied on the air-to-soft-tissue interface. Fur-
thermore, in order to compare the steepness of the edges a sigmoid
function was used to interpolate the data of the line profile. The ex-
tracted steepness-of-fit parameter reflects the increment of blurring
of the edges in the reconstructed slices.
Results:
The acquired PhC slices show a mix of absorption-based contrast and
edge effects, which are further enhanced with an increasing sample-
to-detector distance. The reconstructed PhR slices showed more than
a tenfold higher CNR and more than a 2-fold higher EEI, compared
to the PhC slices for all the given sample-to-detector distances. The
steepness-of-fit parameter increased between 5% and 8% for the PhR
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data scanned at various sample-to-detector distances, meanwhile the
same parameter for the PhC data showed an increase of a minimum of
15%, thereby confirming that the blurring is stronger in the PhC scans,
than in the PhR scans. The histogram of the phase-retrieved data sets
show two clearly distinguished grey value intervals, represented by
air and soft tissue, thus allowing further grey level thresholding.
Discussion:
The results revealed that for PhR data of lungs the CNR can be further
increased by scanning at longer sample-to-detector distances, where
excessive PhC edge effects can be suppressed, while only minor decre-
ment of the sharpness can be expected. The availability of a more
sensitive scanning technique, will allow for a more precise analysis
of lung structural alterations in mouse models with various lung dis-
eases.
6.2 paper ii :
Objective:
To develop a functional imaging approach utilizing in-line free prop-
agation PCX-CT for the assessment of lung structural changes and the
detection of Ba sulfate loaded alveolar macrophages, injected into an
asthmatic mouse model.
Materials and Methods:
An immortalized murine alveolar macrophage cell line (MH-S) was
labelled ex vivo with both a CT contrast agent, as well as a fluo-
rescent label, wherein after they were injected intratracheally into
an Mild Acute Asthma (MAA), Blank (BL) and Control (CN) mice
(CN1 and CN2). Herein after optical imaging was performed by 2-
dimensional (2D) Fluorescence Reflectance Imaging (FRI). The mice
were then sacrificed, lungs were kept in situ and inflated with air,
wherein after they were scanned with Synchrotron Radiation Com-
puted Microtomography (SR µ-CT) in the PhC regime at a sample-to-
detector distance of 30 cm. Otherwise the scanning parameters were
the same as the one used in Paper I. A single-distance in-line PhR algo-
rithm based on the Born equation was applied. The phase-retrieved
images were further divided into thin rectangular VOIs in the hori-
zontal, vertical and transvertical plane and quantitatively analyzed
in terms of amount and structure thickness of the air, soft-tissue
and barium component. Statistical analysis for detecting significant
differences in between the samples was applied using a one-way
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ANOVA test with Tukey 90% simultaneous confidence intervals. The
lungs were then sectioned for histology, wherein after a Periodic
Acid-Schiff (PAS) staining was applied, in order to investigate the
bronchial wall thickness and mucus production. Further investiga-
tions by fluorescence microscopy was also applied, in order to ver-
ify the location of the injected dialkylcarbocyanine dye (DiD) and Ba-
labelled cells inside the tissue of both asthmatic and control mice.
Lung sections were also investigated by means of High-Resolution
Synchrotron-Radiation-based X-ray Phase-Contrast Computed Micro-
tomography (SR HR µ-CT) at an energy of 17.5 keV and PhR based on a
Holo-Tomo reconstruction algorithm was applied.
Results:
In vivo Near Infrared Fluorescence (NIRF) imaging showed a strong
increase in fluorescence intensity over the lung area 24 h after the i.t.
instillation of a DiD - and Ba-labelled macrophages, when compared
with the pre-scan. The results obtained from the SR µ-CT scans re-
vealed a high concentration and specific accumulation of BaSO4 loaded
macrophages inside the asthmatic lung tissue. 3D-renderings of the
segmented lung tissue revealed an increased soft tissue content in the
MAA sample, compared to the healthy controls. Quantitative analysis
of the soft-tissue showed a 61% increase for the PercVol and a 48% in-
crease of the StTh for the MAA sample, in comparison to the controls.
The applied statistical test showed a significant difference between
the MAA lung and all the controls for the PercVol and the StTh param-
eter for both the airways and soft tissue. SR HR µ-CT slices showed an
increased wall thickness for the MAA lung, with respect to a control
lung. BaSO4 loaded macrophages could be observed in both MAA and
CN lung, where they tended to be more closely accumulated in high
dense cell regions in the MAA lung, while being more spread out in
the CN lung. The results from the fluorescent microscopy revealed the
presence of DiD-labelled macrophages in high cellular density areas,
with an increased wall thickness for the MAA lung sample. The CN
lung showed no effects of high dense cellular regions nor increased
wall thickness and the observed macrophages were more widely dis-
tributed. The PAS-staining of lung sections showed an increased wall
thickness in the MAA lung, as well as red dots, related to produced
mucus. The CN lung showed no increased wall thickness nor effects
of mucus production.
Discussion:
This article demonstrated for the first time, to our knowledge, the
usage of BaSO4 loaded macrophages as a contrast agent for CT-based
cell tracking in an experimental allergic airways disease model, while
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simultaneously depicting both lung structural alterations and func-
tional information about the migration of macrophages.
The detection of macrophages inside the lung tissue, using SR µ-CT,
was also supported by results from SR HR µ-CT and fluorescent mi-
croscopy, thus suggesting an active migration of the injected macro-
phages from the airspace into the tissue [34]. Results from PAS-staining
of histology sections also showed an increase of the wall thickness.
6.3 paper iii :
Objective:
To establish a general investigative methodology for quantitative im-
age analysis in the sagittal, coronal and transversal orientation of CT
data sets of lungs (both preclinical and clinical) with various lung
diseases, containing a contrast agent for enhanced imaging.
Materials and Methods:
The preclinical data sets analyzed in this study were the same once
as analyzed in Paper II. A semi-automatic image post processing
methodology was outlined, in order to successfully segment the lung
parenchyma, consisting of a well-established image processing algo-
rithms. Herein after the left and right lung side were divided into
stripe shaped volume of interests VOIs in the transversal, sagittal and
coronal orientation and investigated with the two quantitative param-
eters, PercVol and structural thickness StTh. A set of statistical tests
were followed, in order to determine if there were any statistical sig-
nificant differences in between the samples.
Results:
For the Mild Acute Asthma (MAA) lung, the right lung side showed a
higher content of soft-tissue together with a lower amount of air con-
tent, in comparison with the healthy Blank (BL) and Control (CN) (CN1
& CN2) lungs. The opposite effect was seen in the left lung side for
the MAA lung sample. The denser tissue regions coincided with the
positions of the BaSO4 loaded macrophages. Quantitative analysis of
the tissue PercVol confirmed an increase of 81% and 47% for the right
and left lung side respectively for the MAA lung sample, compared to
the BL, CN1 and CN2 lungs. The tissue StTh showed an increase of 69%
and 37% for the right and left lung side respectively for the MAA lung
sample. The StTh of the BaSO4 loaded macrophage clusters in the right
and left lung side of the MAA lung showed an increase of 38% and
6.3 paper iii : 53
64% respectively, compared to the lung samples CN1 and CN2. The
MAA lung showed a broader variation of the recorded values for the
given two quantitative parameters, in between the left and right lung
side, than the BL, CN1 and CN2 lungs. Statistical analysis revealed that
for the MAA lung the air PercVol was significantly smaller, meanwhile
the tissue PercVol was significantly larger than all the remaining lungs
(BL, CN1 and CN2). For the StTh parameter, significantly smaller values
were detected for the air StTh in the right lung side and significantly
larger values for the tissue StTh for the MAA lung, than compared to all
the remaining lung samples, thus implying that the effect of the asth-
matic attack was stronger in the right lung side. Furthermore, both
the right and left lung side of the MAA lung had significantly higher
StTh values for the Ba sulfate filled macrophage clusters, compared to
all the remaining lung samples.
Discussion:
The hereby presented quantitative parameters (PercVol and StTh) were
shown to be usable for the evaluation of asthma in a preclinical mouse
model.
In general it was revealed that for the PercVol of the given VOIs, cer-
tain directions along the X-, Y-, Z-axis of the scanned lung images
are more sensitive for the detection of smaller local structure vari-
ations, which can otherwise be missed if only evaluating the VOIs
along one preferred axis direction. Prior to defining an overall av-
eraged mean based on data from all these directions, which would
level these smaller location-related variations, it is important to verify
if the smaller variations plays an important aspects or not.
The outlined analysis methodology was also translated from a preclin-
ical level, investigating lung structural differences in asthmatic mice,
to a clinical level, where various lung diseases in patients could be
analyzed by the same protocol. This article therefore helped to con-
firm the importance of preclincial research, using high end imaging
strategies, also for clinical diagnosis, using standard imaging devices.
The outlined analysis methodology protocol was applied only to 3D
data sets obtained by means of CT, but can of course be utilized for
evaluating lung images obtained by other 3D imaging techniques, e.g.
1H MRI. With further developments in the area of both CT and MRI
lung imaging, the presented methodology could serve as in important
tool in evidence based medicine in a near future.
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6.4 paper iv :
Objective:
To evaluate optimized cell uptake methodologies of MRI/CT contrast
agents for dual-modal cell tracking of macrophages in both MRI and
CT.
Materials and Methods:
The same alveolar cell line as used in paper II was cultured with 1)
the same BaSO4 CT contrast agent (containing Sorbitol) as used in pa-
per II and 2) an MRI contrast agent, with CT capabilities, based on
GdNP. 1 million cells were incubated with the contrast agents with 1)
a varying culturing time set to 2h, 4h, 8h and 24 h and 2) varying
culturing concentration between 0.4-1.5 mM Ba and 0.5-2.5 mM GdNP
and a fixed culturing time of 2h. The labelled cells were put into plas-
tic tubes and scanned with SR µ-CT at an energy of 17.0 keV, in order
to evaluate the contrast enhancement. In a second step the effect of
co-loading the cells with both the CT and MRI contrast agent inside
the same cells (for 2+2 hours) was investigated. In a third step it was
investigated if capped/immersed GdNP to Sorbitol would boost the
cell uptake further. The cells were then first scanned with µ-MRI, fol-
lowed by SR µ-CT scanning. A WST-1 test was also applied, measuring
the metabolic activity of the cells, which was also proportional to the
cell viability.
Results:
The BaSO4 loaded macrophages showed a higher contrast enhance-
ment in CT, than the GdNP for both varying incubation time and in-
cubation concentration. It was shown that the cell uptake for both
the contrast agents could be approximated by a negative 2:nd degree
function of the incubation time, while as the cell uptake increased lin-
early as a function of the incubation concentration for both the inves-
tigated contrast agents. The WST-1 test also showed a high metabolic
activity for macrophages loaded with either 1.5-2.0 mM of Gd or 0.75
mM of Ba at incubation times ranging from 2-24 hours.
The co-loading of both GdNP at a concentration of 2.0 mM of Gd and
BaSO4 at a concentration of 0.75 mM of Ba inside the same macrophages
showed a decrease of 11% of the LAC in CT, as well as a decrease of
6% of the T1-contrast in MRI, as in comparison to the obtained signal
from only measuring on BaSO4 or GdNP loaded macrophages in each
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modality.
Macrophages incubated with GdNP capped to Sorbitol for 4-8 hours
at an incubation concentration of 2.0-5.0 mM showed a much higher
metabolic activity of the cells, than pure GdNP incubated according
to the same protocol. Furthermore, it was also observed that when
macrophages were incubated with GdNP capped to Sorbitol for 4-
8 hours at an incubation concentration of 10.0 mM, the quantified
metabolic activity of the cells was similar to that of macrophages in-
cubated with pure GdNP at an incubation concentration of 5.0 mM of
Gd.
Discussion:
CT requires a higher amount of contrast agent in order to be detected,
while as MRI is sensitive enough to detect the effect of lower concen-
trations of contrast agents, where instead a too high concentration of
contrast agent would lead to a so called black out of the T1-weighted
signal in MRI. In this context it is therefore difficult to optimize the
cell loading of GdNP to give an optimal contrast in both CT and MRI at
the same time.
Furthermore, our observations also support the fact that Sorbitol might
both aid the uptake the contrast agent of the cells, as well as acting to
decrease the toxic effects of Gd on the cells.
The idea to of inject a mixture of either GdNP or BaSO4 loaded alveolar
macrophages into an asthmatic mouse, might therefore be a valid al-
ternative path, in order to keep both the CT and MR-signal maximized.
6.5 paper v :
Objective:
To investigate the feasibility of dual-modal CT-MRI cell tracking, macro-
phages loaded with either an MRI or CT contrast agent were injected in
a mouse model with Severe Acute Asthma (SAA), by means of SR µ-CT
and µ-MRI.
Materials and Methods:
In this study the preclinical data set consisted of a mouse model with
SAA, intracheally injected with both 1) 4 million alveolar macrophages
loaded with commercial BaSO4 contrast agent for CT or 2) 2 million
alveolar macrophages loaded with GdNP as a contrast agent for MRI.
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The lung samples were scanned ex vivo at an energy of 22 keV and
with a 9.4 Tesla µ-MRI scanner using short Time to Echo (TE) of 2 ms.
The outlined image processing protocol mentioned in Paper III, was
hereby applied on both CT and MRI lung data sets, prior to the fol-
lowing image registration of the CT and MRI data sets. The following
quantitative parameters were computed from both the CT and MRI
lung data sets: 1) soft tissue mean value and 2) soft tissue percentage
volume. These parameters were calculated from each slice of every
respective data set. Statistical analysis for determining the presence
of any significant differences in between the samples was performed,
followed by a correlation analysis between the extracted MRI, CT and
histology parameters.
Results:
For the CT lung data sets, an increased soft tissue PercVol of 130%
and 178% were detected in the SAA Ba/GdNP and SAA lung respec-
tively, compared to the Severe Control (SCN). The SAA Ba/GdNP sam-
ple presented high absorbing spots found inside the denser tissue
regions. For the corresponding MRI lung data sets, an increased soft
tissue PercVol of 105% and 8% were detected in the SSA Ba/GdNP and
SAA lung respectively, compared to the control lung SCN. The soft tis-
sue mean value of the CT data sets showed a decrease of 3% and
2% for the SSA Ba/GdNP and SAA lung respectively, compared to
the SCN lung. For the corresponding MRI lung data sets, an increased
soft tissue mean value of 5% and 4% were instead seen for the SSA
Ba/GdNP and SAA lung respectively, compared to the SCN lung. The
applied correlation analysis revealed a total negative correlation be-
tween the soft tissue mean value in CT and the soft tissue mean value
in MRI.
The fused images showed that in the very same positions of the BaSO4
loaded macrophage clusters, as imaged by CT, there was an absence
of the T1-contrast of the soft-tissue in the MR image, as indirectly in-
creased by the presence of non-clustered GdNP loaded macrophages
in the tissue.
Discussion:
The results from the correlation analysis suggest that the soft tissue
in the asthmatic samples has a lower density, as observed by CT and
a higher water content, as observed in MRI. Dual modal CT-MRI cell
tracking of macrophages loaded with a CT or MRI contrast agent, will
in each modality be detected in different manners. The way that the
presence of contrast agent loaded macrophages are detected either by
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CT or MRI is related to the very technical differences in the way that
images are created in the two modalities CT and MRI.
In CT the LAC needs to be as high as possible, which is fulfilled when
macrophages loaded with a CT contrast agent, e.g. BaSO4 are clustered
together, with a diameter equal or bigger than the image resolution.
In MRI on the other hand the presence of macrophages stained with a
positive MRI contrast agent, e.g. Gd is detected indirectly through the
increase of the T1-weighted-signal, coming from the surrounding 1H
protons (either inside the cells or the from the soft tissue), where their
relaxation speed is slowed down by Gd. This study hence reported dif-
ferent values for the amount of soft tissue PercVol detected either by CT
or MRI. The observed soft tissue in the CT-slices is in fact a mixture of
both soft tissue and produced mucus (which are inseparable by CT),
where the latter is due to an indirect enhancement of the T1-contrast,
due to the presence of GdNP loaded macrophages in the tissue.
The observed decrease of the T1-contrast of the soft-tissue around the
positions of the BaSO4 loaded macrophages, is most likely related to
a black out of the T1-weighted signal, due to a too high concentra-
tion of Gd, under the consideration that the GdNP and BaSO4 loaded
macrophages are clustered in the same regions and possibly also fur-
ther effected by the diamagnetic properties of Ba being able to cause
a decrease of the T1-contrast. In this context CT allows the detec-
tion of clustered macrophages, while as MRI permits an indirect T1-
enhancement of the lung-tissue, due to non-clustered macrophages
present in the tissue. In context the combination of using both a con-
trast agent for CT and one for MRI in a dual-modal CT-MRI approach
permits us to extract true synergistic information about the role of
macrophages in asthmatic lung tissue, which could not have been re-
alized if only performing the study in only one of the two modalities.
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F I N A L D I S C U S S I O N
The aim of the here presented thesis was to evaluate if Gadolinium
nanoparticles (GdNP)s that have already been proven to be a good
Contrast Agent (CA) in MRI also can act as a dual-modal CA for both
MRI and CT. As the contrast in CT is related to the atomic number,
Z and ultimately the X-ray Mass Attenuation Coefficient (MAC) of
the scanned material, which are both higher in Gd, compared to for
instance Ba, which is routinely used as a CA for CT, the usability of
GdNP also for CT presents a valid hypothesis.
However, since it is a well-known fact that the MR-signal decays more
rapidly if the Gd concentration is too high in one spot, the main chal-
lenge of this work was to use GdNP at a relative low concentration of
Gd for CT. Therefore, Synchrotron in-line Phase Contrast (PhC) CT with
its known increase in sensitivity was used to investigate the CT capa-
bilities of GdNP. Today effective clinical contrast agents already exist
for both MRI and CT, although these CAs lack strategies for specifi-
cally targeting sites of interest. Therefore the focus in this thesis was
turned to the usage of macrophages, having the possibility to engulf
large particles, allowing an effective loading of the hereby discussed
GdNPs and exploiting them as carriers of the CA to home to inflamma-
tory sites.
The results in this thesis showed that GdNP can be detected by means
of Synchrotron Radiation Computed Microtomography (SR µ-CT). How-
ever, the crucial factor when selecting a CA to be used for cell tracking
with CT, is not solely dependent on the MAC-value, where the main
factor is instead related to the uptaken amount of the material by the
cells, while still making sure that the cell viability is acceptable. In
Paper IV it was shown that Gadolinium nanoparticles (GdNP) can be
loaded into immune cells, such as murine alveolar macrophages and
a contrast difference between GdNP loaded and pure macrophages
could be observed by both CT and MRI. As a reference for determining
an optimal contrast in CT, a pure CA developed for CT and based on
Barium Sulfate (BaSO4) in a suspension of Sorbitol (sugar molecule)
was used. The uptake of GdNP could however be optimized by in-
creasing the Gd concentration, the incubation time or by immersing
the GdNP in Sorbitol, as shown in Paper IV. However, while trying to
optimize the Gd uptake for CT, a too high concentration of Gd leads
to a decay of the T1-weighted signal in MRI, as well as to a decreased
cell viability. The investigated GdNP can hence not be optimized for
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both CT and MRI at the same time.
The usage of a Gd containing dual-modal CA for both CT and MRI
could therefore benefit from the combination with a metal primar-
ily used in CT CA, such as gold in the work presented by Alric et
al. [18] using gadolinium chelate coated gold nanoparticles and or
with iodine as proposed by Ahmad et al. [17] using Iodine Gadolin-
ium nanoparticles (ICGdNP)s. In a parallel study (not shown in this
thesis work), we also investigate the CT contrast capabilities of Zinc
Gadolinium nanoparticles (ZnGdNP) [80, 81, 82]. The measured LAC of
pure ZnGdNP in solution was much higher, than for pure GdNP. How-
ever, the contrast differences of ZnGdNP loaded macrophages, was
only slightly higher than for GdNP loaded macrophages, thus sug-
gesting that the crucial factor for performing cell tracking with CT is
still related to the cell uptake of the given CA.
In order to permit an optimal contrast of CA loaded macrophages in
both CT and MR a mixture of GdNP and BaSO4 loaded murine alveo-
lar macrophages were used at a ratio of 2:4 million cells and injected
into mice of an allergic airway inflammation model (mimicking hu-
man asthma), to show the potential usage of the CAs. Furthermore,
it was also assumed that the BaSO4 and GdNP loaded macrophages
behaved in the same way. The results revealed complementary in-
formation about the macrophage migration patterns, where clustered
macrophages could be observed by means of both SR µ-CT, meanwhile
the indirect effect of freely distributed non-clustured macrophages
could be observed, as an increment of the T1-contrast of the soft-
tissue, image by µ-MRI, as shown in Paper V. Furthermore, fused im-
ages of the CT and MRI lung data set showed that the positions of the
BaSO4 loaded macrophage clusters imaged by CT, corresponded to po-
sitions of missing T1-enhanced soft-tissue contrast in the MR image,
mainly related to a black out of the T1-weighted-signal, due to a too
high concentration of Gd in these spots.
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F U T U R E O U T L O O K
The work performed in this thesis presents a general pipeline analy-
sis approach for evaluating the potentials of dual-modal CT-MRI cell
tracking using intracellular CAs and is hence not limited to the used
CAs in this thesis. The initial idea was however to investigate if GdNP
could be used as an intracellular CA for both CT and MRI. Since GdNP
presented further challenges related to the optimal concentration need-
ed for detection in MRI and CT and followed toxicity issues, a combi-
nation with BaSO4 was therefore performed. Furthermore, BaSO4 was
initially used for testing the detectability of CA loaded macrophages
by means of SR µ-CT, as shown in Paper II.
Although combinations of Gd with other materials such as gold and
iodine, primarily used in CAs for CT, have already been proven effi-
cient [18, 17], these studies does not reveal the applicability of these
CAs as intracellular CAs for the purpose of performing cell tracking
in both CT and MRI. The crucial factor for being able to perform MRI-
CT cell tracking is therefore dependent on the uptaken material of
the cells, where for an optimal contrast in CT it is crucial that the CT
core material for is packed as close as possible inside the cell (high
intracellular concentration) for increased contrast, meanwhile for op-
timal contrast in MRI it is on the contrary important that the MRI core
material is more spread out within the cell (low intracellular concen-
tration), in order to avoid a decay of the MR signal.
A common issue always discussed for the use of nanoparticles is their
ultimate fate within the body. Therefore, it would also be interesting
to study the fate of the GdNP once the CA loaded macrophages even-
tually die. This could e.g. be done by attaching a radioactive tracer to
the GdNP and then using a high sensitive gamma counter to measure
the radioactivity from each organ of the mouse.
Future aspects of the hereby presented work would also include sur-
face modifications of the GdNP by attaching a tag for specific recog-
nition of a given surface molecule present on a given cell type of
interest, thereby allowing specific cell targeting. Such an approach
is however not really needed when dealing with macrophages, since
macrophages are capable of engulfing all foreign pathogens.
Since smaller particles are usually taken up unspecifically by cells in
every organ of the body, another way of realizing specificity without
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modifying the surface, would be to only increase the size of the GdNP,
so that predominantly macrophages are capable of engulfing them.
This would allow a direct injection of pure GdNP into asthmatic mice,
followed by a homing of the indulgent macrophages (already present
in the host) to the inflammatory sites, thereby allowing to study the
role of alveolar macrophages in asthma in more detail. Such an idea
would also remove the need for in-vitro cell labeling approaches us-
ing immortalized macrophages.
Since size modification of the GdNP would make them specific for
predominantly macrophages, a further theranostic approach could be
to couple the GdNP to a drug, that would be released once the particle-
drug complex breaks down and locally administrate the drug at the
site of inflammation, due to the homing of the macrophages here.
Recent studies have shown that air-filled micro bubbles, primarily de-
veloped as a CAs for Ultrasound (US) can be used as CA in the PhC
regime of CT [83]. Therefore, a future idea would be to coat air-filled
micro bubbles with a layer of GdNP, there by allowing for both op-
timal detection in both PhC CT and MR at the same time. Such an
approach would hence rule out the need for a CT core material, since
PhC CT is more sensitive than Abs based CT, while as the issue of
the decaying MR-signal, due to a too high Gd concentration can be
avoided.
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